Abstract
Background In Scotland, the effects of the COVID-19 pandemic on women’s access to contraception are unknown. Globally, COVID-19 restrictions have led to a shift to telehealth service delivery alongside a reduction in contraceptive provision. Research into whether the effects of COVID-19 on contraception have abated after restrictions have been lifted is lacking.
Methods This is a retrospective longitudinal study of prescribing data from the Scottish Health and Social Care Open Data repository (https://www.opendata.nhs.scot) between January 2016 and January 2023. Contraceptives were extracted and categorised using truncated British National Formulary codes and analysed using R. Contraceptive provision was compared across four periods: pre-COVID-19 (01/01/2016–23/03/2020), lockdown (24/03/2020–29/05/2020 & 05/01/2021–26/04/2021), restrictions (30/05/2020–04/01/2021 & 27/04/2021–30/04/2022), and post-COVID-19 (01/05/2022–01/01/2023).
Results During lockdowns, contraceptive prescribing in Scotland decreased by 82.90% of pre-COVID-19 levels. This trend was more severe for long-acting reversible contraception which fell to 11.80% of pre-COVID-19 prescriptions. After COVID-19, the level of contraceptive prescribing has risen to 108.23% of its pre-pandemic level. Large increases in subcutaneous medroxyprogesterone acetate (499.05%), progestogen-only pills (125.07%), the patch (165.09%), levonorgestrel-IUS (112.54%), and ulipristal acetate emergency contraception prescribing (357.97%). Conversely, combined oral contraceptive pills (75.04%), Cu-IUD (83.63%), the implant (81.10%), and levonorgestrel emergency contraception (67.42%) prescribing has decreased.
Conclusions COVID-19 vastly decreased contraceptive prescribing during lockdowns in Scotland. Post-COVID-19, changes in contraceptive prescribing within Scottish general practices are reported, with implications for health policy and service delivery planning.
Availability of Data & Code All code and data used are fully available from Zenodo (doi:10.5281/zenodo.8310085)
The raw dataset used is also publicly available from the Scottish Health and Social Care Open Data repository (opendata.nhs.scot).
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not- for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The raw dataset used is also publicly available from the Scottish Health and Social Care Open Data repository (opendata.nhs.scot).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All code and data used are fully available from Zenodo (doi:10.5281/zenodo.8310085) The raw dataset used is also publicly available from the Scottish Health and Social Care Open Data repository (opendata.nhs.scot).
Abbreviations
- BNF
- British National Formulary
- COCP
- Combined oral contraceptive pill
- Cu-IUD
- EC Copper intra-uterine device Emergency contraception
- LARC
- Long-acting reversible contraception
- LNG-IUS
- Levonorgestrel intra-uterine system
- NHS
- National Health Service
- POP
- Progestogen-only pill
- UK
- United Kingdom
